# A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

> **NCT00443534** · NA · COMPLETED · sponsor: **Pfizer** · enrollment: 123 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** SU011248

## Key facts

- **NCT ID:** NCT00443534
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2013-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00443534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00443534, "A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00443534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*